Skandinaviska Enskilda Banken Ab (Publ) Charles River Laboratories International, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$24.3 Billion
Q3 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 75 shares of CRL stock, worth $12,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 144 47.92%

Holding current value

$12,603

Previous $21,000 47.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$145.57 - $178.99 $10,044 - $12,350	-69 Reduced 47.92%	75 $11,000
Q1 2025 May 07, 2025	SELL	$150.52 - $190.14 $1.38 Million - $1.74 Million	-9,144 Reduced 98.45%	144 $21,000
Q3 2024 Nov 07, 2024	SELL	$187.96 - $245.29 $12 Million - $15.7 Million	-64,095 Reduced 87.34%	9,288 $1.83 Million
Q2 2024 Aug 13, 2024	SELL	$206.39 - $268.73 $7.8 Million - $10.2 Million	-37,781 Reduced 33.99%	73,383 $15.2 Million
Q1 2024 May 13, 2024	SELL	$203.52 - $273.43 $60,445 - $81,208	-297 Reduced 0.27%	111,164 $30.1 Million
Q3 2023 Nov 09, 2023	SELL	$194.44 - $217.61 $4,472 - $5,005	-23 Reduced 0.02%	111,461 $21.8 Million
Q2 2023 Aug 07, 2023	SELL	$183.71 - $210.25 $455,600 - $521,420	-2,480 Reduced 2.18%	111,484 $23.4 Million
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $152,168 - $206,116	-793 Reduced 0.69%	113,964 $23 Million
Q4 2022 Feb 08, 2023	BUY	$197.11 - $250.07 $112,352 - $142,539	570 Added 0.5%	114,757 $25 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $3.57 Million - $4.9 Million	19,577 Added 20.69%	114,187 $22.5 Million
Q2 2022 Aug 10, 2022	BUY	$204.13 - $302.4 $2.84 Million - $4.2 Million	13,889 Added 17.21%	94,610 $20.2 Million
Q1 2022 May 11, 2022	BUY	$255.51 - $362.11 $2.61 Million - $3.7 Million	10,207 Added 14.48%	80,721 $22.9 Million
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $2.66 Million - $3.4 Million	-7,568 Reduced 9.69%	70,514 $26.5 Million
Q3 2021 Nov 10, 2021	BUY	$372.64 - $458.3 $24.1 Million - $29.6 Million	64,665 Added 481.96%	78,082 $32.2 Million
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $2.33 Million - $2.94 Million	7,911 Added 143.68%	13,417 $4.96 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $83,889 - $100,625	336 Added 6.5%	5,506 $1.6 Million
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $61,494 - $69,975	-277 Reduced 5.09%	5,170 $1.29 Million
Q3 2020 Nov 12, 2020	BUY	$175.56 - $226.45 $934,681 - $1.21 Million	5,324 Added 4328.46%	5,447 $1.23 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $14,617 - $23,335	123 New	123 $21,000

Others Institutions Holding CRL

# of Institutions

637

Shares Held

52.9M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Charles River Laboratories International, Inc. Transaction History